Get started
Author

Nathalie Chansard

Characterization of cell death induced by vinflunine, the most recent Vinca alkaloid in clinical development
2002 · A Kruczynski, C Etiévant, et al. · British Journal of Cancer · 39
PDF
International Society for Therapeutic Ultrasound Conference 2016
2017 · Brian Fowlkes, Pejman Ghanouni, et al. · Journal of Therapeutic Ultrasound · 22
PDF
Decreased Nucleotide Excision Repair Activity and Alterations of Topoisomerase IIα Are Associated with thein VivoResistance of a P388 Leukemia Subline to F11782, a Novel Catalytic Inhibitor of Topoisomerases I and II
2004 · Anna Kruczynski, Jean-Marc Barret, et al. · Clinical Cancer Research · 21
Myrtus communis and Celastrol enriched plant cell culture extracts control together the pivotal role of Cutibacterium acnes and inflammatory pathways in acne
2023 · Céline Mias, Nathalie Chansard, et al. · Journal of the European Academy of Dermatology and Venereology · 15
PDF
Enhancement of Fluorescent Probe Penetration into Tumors In Vivo Using Unseeded Inertial Cavitation
2016 · Fabrice Prieur, Arnaud Pillon, et al. · Ultrasound in Medicine & Biology · 7
Metabolomics in Scalp Seborrheic Dermatitis Evidenced Key Changes in Inflammatory Markers Following a 10-Week Scalp Care Scheme with an Anti-dandruff Shampoo
2026 · Camille Géniès, Martine Maître, et al. · Dermatology and Therapy · 2
PDF
618 Efficacy of Silybum marianum fruit extract in inhibiting sebogenesis
2019 · L. Garidou, n Chansard, et al. · Journal of Investigative Dermatology · 2
686 Efficacy of Silybum marianum fruit extract in inhibiting sebogenesis
2019 · L. Garidou, N. Chansard, et al. · Journal of Investigative Dermatology · 2
273 Use of bioluminescence imaging and quantitative RT-PCR to monitor tumor progression and treatment response in orthotopic AML mouse models: Application to the targeted cytotoxic agent F14512
2010 · L. Creancier, A. Pillon, et al. · European Journal of Cancer Supplements · 1
Abstract B186: Preclinical antileukemic activity of F14512, a novel targeted cytotoxic agent
2009 · Anna Kruczynski, Christian Recher, et al. · Molecular Cancer Therapeutics · 1
374 Exploring the Pharmacological Impact of Broussonetia papyrifera Extract on the JAK/STAT pathway for the support of atopic dermatitis burden
2025 · F Lestienne, P Bianchi, et al. · Journal of Investigative Dermatology
348 Two botanical extracts combine their effectiveness to impair the pruritogenic pathway associated with type 2 in atopic dermatitis
2024 · F. Lestienne, L. Garidou, et al. · Journal of Investigative Dermatology
1002 Interactome expertise: Integrative approach to understand seborrheic dermatitis of the scalp and demonstrate the pharmaco-clinical efficacy of a shampoo containing an antifungal association ciclopiroxolamine/piroctone olamine
2023 · M. Maitre, F. Melanie, et al. · Journal of Investigative Dermatology
PDF
221 Pharmacological properties of Myrtacine and Celastrol extracts on Cutibacterium acnes and immuno-inflammatory cascade involved in acne
2021 · C. Mias, M. Maitre, et al. · Journal of Investigative Dermatology
925 F14512, a Polyamine Vectorized Anti-cancer Drug Exhibits a Marked Antileukemic Activity, Alone and in Combination With AraC
2012 · A. Kruczynski, A. Pillon, et al. · European Journal of Cancer
Abstract 2747: Synergistic antileukemic activity of F14512 in combination with AraC
2012 · Isabelle Vandenberghe-Huez, Arnaud Pillon, et al. · Cancer Research
Abstract A214: F14512, a novel targeted cytotoxic agent exhibits a marked antileukemic activity, alone and in combination with AraC.
2011 · Anna Kruczynski, Arnaud Pillon, et al. · Molecular Cancer Therapeutics
R54: Activité de l’inhibiteur sélectif de la sous-unité p110 alpha de la PI3-kinase dans les leucémies aiguës myéloïdes
2010 · F. Vergez, N. Gallay, et al. · Bulletin du Cancer
Preclinical antitumor activity of F14512, a novel targeted cytotoxic agent
2007 · Anna Kruczynski, Isabelle Vandenberghe, et al. · Molecular Cancer Therapeutics
518 Alterations of topoisomerase IIalpha, associated with in vivo resistance to tafluposide, are partially reversible
2004 · A. Kruczynski, L. Creancier, et al. · European Journal of Cancer Supplements
Works count: 20
Citation count: 112
H-index: 5
I10-index: 4
Year
Topic
Type